GlassScriptPhysician profile
David A Solomon
NPI 1881080190
$15,542.21
in general payments reported to CMS, 2019-2025
14 companies · $309 in 2025
The $309 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $4,307 · 2021: $10K · 2022: $86.87 · 2023: $171 · 2024: $450 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $931.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $930.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $9,039.85 | 2020-2025 | Pico 14 |
| Arthrex, INC. | $4,003.06 | 2021-2022 | |
| Mid-Atlantic Surgical Systems, LLC | $1,253.08 | 2021 | |
| Stryker Corporation | $367.50 | 2021-2024 | Tornier Perform Reversed Augmented Glenoid, Blueprint Patient Specific Instrumentation |
| Seapearl East, INC | $279.16 | 2021-2024 | |
| Ferring Pharmaceuticals INC. | $193.41 | 2021-2025 | Euflexxa |
| Globus Medical, INC. | $178.32 | 2024 | Clavicular Fracture Fixation, Distal Humerus Fracture System |
| Alpha Orthopedic Systems | $56.09 | 2021 | |
| Zimmer Biomet Holdings, INC. | $49.45 | 2023 | Quattro |
| Bioventus LLC | $38.43 | 2021-2024 | Durolane |
| Vertex Pharmaceuticals Incorporated | $33.07 | 2025 | |
| Lundbeck LLC | $19.55 | 2024 | Vyepti |
| Neurelis, INC. | $16.52 | 2023 | Valtoco |
| Vericel Corporation | $14.72 | 2023 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Solomon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.